Bend Research has licensed its spray-dried dispersion (SDD) technology to Eli Lilly and Co. This technology is designed to improve the bioavailability of compounds with low aqueous solubility and has been applied to hundreds of compounds at various stages of development. Lilly will also have access to Bend Research’s portfolio of other drug delivery technologies. Also, as part of an existing agreement, Bend Research will continue to provide formulation, development, analytical, engineerin...